Skip to main content

Record revenue, Singapore expansion for Orthocell

08/10/2024 - 10:59

Bookmark

Save articles for future reference.

Murdoch-based Orthocell has received regulatory approval to commence sales of Remplir in Singapore, as the listed biotech company posts a second consecutive quarter of record revenue.

X

To read our articles you will need to either login or subscribe.